The Dow Jones Industrial Average is now at 43,917.68 points, up 3.56 points.Hokkaido, Japan will levy accommodation tax from 2026, and it is estimated that the annual tax revenue will reach 4.5 billion yen. On December 12, the plenary session of Hokkaido Parliament of Japan passed a regulation to levy accommodation tax on tourists staying in hotels and hotels in Daodao, which is expected to be implemented from April 2026. The accommodation fee per person per night is 500 yen if it is above 50,000 yen (about 2,380 yuan), 200 yen if it is between 20,000 and 50,000 yen, and 100 yen if it is below 20,000 yen. It is estimated that the annual tax revenue will reach about 4.5 billion yen, which will be used for transportation infrastructure construction and "excessive tourism" (tourism pollution) countermeasures.Maiwell Technology rose more than 11% to a record high, and announced a breakthrough in customized high-bandwidth memory. Maiwell Technology rose more than 11% in intraday trading to US$ 121.86, with its share price reaching a record high and its market value exceeding US$ 100 billion. Maywell Technology announced on Wednesday that the company has made a breakthrough in customized high-bandwidth memory (HBM) for artificial intelligence processors. It is reported that the new artificial intelligence accelerator architecture (XPU) will increase computing power by 25%, memory by 33%, and improve energy efficiency. The company is cooperating with Micron Technology, Samsung and SK Hynix to customize HBM processors for accelerators.
Nasdaq hit a record high in intraday trading, up 0.8%.Canada asked the Labor Committee to put Canadian postal workers back to work.Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).
This week, the Shenzhen Stock Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, and the Shenzhen Stock Exchange released regulatory trends: 1. Regulatory trends of listed companies (December 6-December 12, 2024) From December 6 to December 12, the Exchange took disciplinary action against one violation, involving information disclosure and standardized operation violations; Supervision letters were issued for 9 violations, 3 related to information disclosure and standardized operation violations, and 6 related to securities trading violations. This week, 18 inquiry letters and 5 other letters were sent out. II. Market Trading Supervision Dynamics (December 9-December 13, 2024) From December 9 to December 13, the Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, involving abnormal trading situations such as intraday bidding, false declaration, etc. Focus on monitoring "*ST Tongzhou" with abnormal stock price fluctuation recently; A total of 9 major events of listed companies were verified, and 3 clues of suspected illegal cases were reported to the CSRC. (Issued by Shenzhen Stock Exchange)Jiaying Pharmaceutical Co., Ltd.: It plans to buy back 7 million to 13.5 million shares. Jiaying Pharmaceutical announced that it plans to use its own funds to buy back some issued RMB common shares (A shares) by centralized bidding for the implementation of employee stock ownership plan or equity incentive. The price of repurchased shares is not higher than 9.80 yuan/share (inclusive), and the number of shares to be repurchased is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; And no more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. The repurchase period is within 12 months from the date when the company's board of directors deliberated and approved the share repurchase plan.Official of the National Development and Reform Commission: More active and promising, and the Central Economic Work Conference highlights the large space for follow-up policies. Liu Jianxing, deputy director of the Institute of Market and Price of the National Development and Reform Commission, believes that expanding domestic demand in an all-round way is an effective way to cope with external shocks and stabilize economic operation, and it is also a long-term strategy to enhance development initiative. In the current situation of increasing export uncertainty, expanding domestic demand in an all-round way plays a vital role in stabilizing economic growth, promoting economic restructuring and transformation and upgrading. (Xinhua Finance)
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide
Strategy guide
Strategy guide
Strategy guide
Strategy guide
12-14
Strategy guide 12-14